510(k) K190882
K190882 is an FDA 510(k) premarket notification submitted by Lemaitre Vascular for the device "XenoSure Biologic Patch". The FDA issued a decision of Substantially Equivalent on Feb 13, 2020. The device falls under product code PSQ (Intracardiac Patch Or Pledget, Biologically Derived), a Class II device regulated under 21 CFR 870.3470. Lemaitre Vascular has 34 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 13, 2020
- Date Received
- Apr 4, 2019
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Intracardiac Patch Or Pledget, Biologically Derived
- Device Class
- Class II
- Regulation Number
- 870.3470
- Review Panel
- CV
- Submission Type
- 510(k)
To repair defects, to be used for patch grafting, to repair tissue, and to buttress sutures in the heart and vasculature.
Need the full FDA record for Lemaitre Vascular? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.